Rovin Capital Bristol Myers Squibb CO Transaction History

Rovin Capital

$361 Million
Q3 2025

A detailed history of Rovin Capital transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Rovin Capital holds 10,622 shares of BMY stock, worth $497,215. This represents 0.13% of its overall portfolio holdings.

Number of Shares

10,622

Previous 9,526 11.51%

Holding current value

$497,215

Previous $441,000 8.62%

% of portfolio

0.13%

Previous 0.13%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 29, 2025	BUY	$43.31 - $48.98 $47,467 - $53,682	1,096 Added 11.51%	10,622 $479,000
Q2 2025 Aug 06, 2025	SELL	$44.12 - $59.6 $62,562 - $84,512	-1,418 Reduced 12.96%	9,526 $441,000
Q1 2025 Apr 25, 2025	SELL	$53.9 - $63.11 $181,750 - $212,806	-3,372 Reduced 23.55%	10,944 $667,000
Q4 2024 Jan 14, 2025	SELL	$51.92 - $59.94 $145,895 - $168,431	-2,810 Reduced 16.41%	14,316 $810,000
Q3 2024 Nov 01, 2024	BUY	$39.66 - $51.75 $168,792 - $220,248	4,256 Added 33.07%	17,126 $886,000

Q2 2024 Jul 18, 2024	BUY	$40.25 - $52.99 $303,726 - $399,862	7,546 Added 141.74%	12,870 $534,000
Q1 2024 Apr 22, 2024	BUY	$47.98 - $54.4 $255,445 - $289,625	5,324 New	5,324 $289,000
Q1 2023 Apr 05, 2023	SELL	$65.71 - $74.53 $1,117 - $1,267	-17 Reduced 0.57%	2,945 $204,000
Q4 2022 Jan 23, 2023	SELL	$68.48 - $81.09 $3,150 - $3,730	-46 Reduced 1.53%	2,962 $213,000
Q3 2022 Oct 25, 2022	SELL	$0.13 - $76.84 $14 - $8,375	-109 Reduced 3.5%	3,008 $214,000
Q2 2022 Jul 22, 2022	SELL	$72.62 - $79.98 $327,734 - $360,949	-4,513 Reduced 59.15%	3,117 $240,000
Q1 2022 Jun 13, 2022	SELL	$61.48 - $73.72 $240,079 - $287,876	-3,905 Reduced 33.85%	7,630 $557,000
Q4 2021 Feb 24, 2022	BUY	$53.63 - $62.52 $618,622 - $721,168	11,535 New	11,535 $719,000

Others Institutions Holding BMY

# of Institutions

2,680

Shares Held

1.58B

Call Options Held

28M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rovin Capital , based on Form 13F filings with the SEC.

News

Stay updated on Rovin Capital with notifications on news.

Account